Global Cell and Gene Therapy Manufacturing QC Market 2023-2033: PCR Technology Dominates the Market: A Closer Look at Key Technologies in QC
18 août 2023 04h23 HE
|
Research and Markets
Dublin, Aug. 18, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis: Focus on Therapy Type, Offering, Process, Technology, Application, and...
Viral Vectors and Plasmid DNA Manufacturing Market - Increasing Demand for Gene Therapies and Vaccines Propelling Growth
03 août 2023 08h43 HE
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Viral Vectors and Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Unlocking New Frontiers in Malignancy Treatment: Cell Therapy Clinical Activity and Process Automation Research Report 2023
03 août 2023 07h43 HE
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Clinical Activity and Process Automation" report has been added to ResearchAndMarkets.com's offering. Cell therapy, a revolutionary...
Advances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New Report
21 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer including...
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023
20 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics" report has been added to ResearchAndMarkets.com's offering. The...
Autolus Therapeutics announces publication in Cancer Immunology Research
27 juin 2023 07h00 HE
|
Autolus Therapeutics plc
LONDON, June 27, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
US Cell & Gene Therapy Market Report 2023 to 2028 - Featuring bluebird bio, Gilead Sciences, Spark Therapeutics, Novartis and Bristol-Myers Squibb Among Others
23 juin 2023 04h13 HE
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "US Cell & Gene Therapy Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. The US cell and gene...
Global Cell Therapy Market Report 2023: Sector is Expected to Reach $62.39 Billion by 2030 at a CAGR of 14.2%
14 juin 2023 05h33 HE
|
Research and Markets
Dublin, June 14, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Market Size, Share, & Trends Analysis Report 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The global cell...
Autolus Therapeutics Presents Positive Results from Pivotal Phase 2 FELIX study in adult r/r B-ALL at ASCO
02 juin 2023 07h00 HE
|
Autolus Therapeutics plc
76% of patients treated with obe-cel in the FELIX study achieved a response (CR/CRi), primary endpoint has been met based on previously communicated interim analysisPotential best in class...
Global T-Cell Immunotherapy Market Report 2023-2028: Increasing Developments in CAR T-Cell Therapy for Solid Tumors Fuels Growth
01 juin 2023 05h18 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Immunotherapy Market (2023-2028) by Therapy Type, Mechanism of Action, Product Class, Indication, Modality, and Geography, Competitive...